| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |